Puma Biotechnology Q4 Earnings Report: What Investors Need to Know
Benzinga Insights 8 months ago
Earnings
Puma Biotechnology (NASDAQ:PBYI) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:05 PM.
Here's a brief overview of the earnings report.
Earnings
Puma Biotechnology beat estimated earnings by 42.86%, reporting an EPS of $0.3 versus an estimate of $0.21.
Revenue was up $16.40 million from the same period last year.
Historical Earnings Summary
Last quarter the company beat on EPS by $0.13 which was followed by a 22.24% increase in the share price the next day.
Here's a look at Puma Biotechnology's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.08 | 0.07 | 0.03 | 0.14 |
| EPS Actual | 0.21 | 0.15 | 0.10 | 0.43 |
| Revenue Estimate | 49.95M | 51.27M | 44.55M | 52.50M |
| Revenue Actual | 54.50M | 49.20M | 46.00M | 59.10M |
To track all earnings releases for Puma Biotechnology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.